Zoekresultaten - 4 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
related death. Relative vaccine effectiveness also waned with time, falling to ≤50% after 24 weeks. In the most recent estimate, between February and March 2023, rVE of the second booster ranged between ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
COVID-19-related death declined over time for both age groups, while the second booster VE against death remained above 80% for the ≥80 years. CONCLUSIONS: Successive vaccine boosters played a relevant role in ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
following the autumn vaccination campaign of 2022, compared to those who did not receive a vaccine during this time. Health Topics: Vaccin Vaccin Vaccin Service: Épidémiologie des maladies infectieuses ...
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
DNA-primed-protein-boosted animals, compared to those that received only the DNA vaccination. Moreover, these responses appeared to be better sustained over time. Antibodies were readily produced by all three methods of ...